Psilocybin in the treatment of obsessive-compulsive disorder: What do we know so far?
European Psychiatry April 1, 2021 Nelson Descalço, Ana Beatriz Medeiros, Cátia Fernandes Santos et al. 1 citation
Introduction Psilocybin is a naturally occurring plant alkaloid in mushrooms and a prodrug of psilocin. It is a serotonin receptor (5-HT2A) agonist and known psychedelic, with similar hallucinatory properties to lysergic acid diethylamide (LSD). It has been identified as a safe and effective option in treatment-resistant depression. Literature focus mainly on its use on depressive but its...